Abstract:Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Genetic testing has become standard of care for patients with long QT syndrome (LQTS), providing diagnostic, prognostic, and therapeutic information for both probands and their family members. However, up to a quarter of patients with LQTS do not have identifiable Mendelian pathogenic variants in the currently known LQTS-associated genes. This absence of genetic confirmation, intriguingly, does not lessen the severity of LQTS, with the prognosis in these gene-elusive patients with unequivocal LQTS mirroring genotype-positive patients in the limited data available. Such a conundrum instigates an exploration into the causes of corrected QT interval (QTc) prolongation in these cases, unveiling a broad spectrum of potential scenarios and mechanisms. These include multiple environmental influences on QTc prolongation, exercise-induced repolarization abnormalities, and the profound implications of the constantly evolving nature of genetic testing and variant interpretation. In addition, the rapid advances in genetics have the potential to uncover new causal genes, and polygenic risk factors may aid in the diagnosis of high-risk patients. Navigating this multifaceted landscape requires a systematic approach and expert knowledge, integrating the dynamic nature of genetics and patient-specific influences for accurate diagnosis, management, and counseling of patients. The role of a subspecialized expert cardiogenetic clinic is paramount in evaluation to navigate this complexity. Amid these intricate aspects, this review outlines potential causes of gene-elusive LQTS. It also provides an outline for the evaluation of patients with negative and inconclusive genetic test results and underscores the need for ongoing adaptation and reassessment in our understanding of LQTS, as the complexities of gene-elusive LQTS are increasingly deciphered.

Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders

Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management

Inherited conditions of arrhythmia: translating disease mechanisms to patient management

Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II

Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies

Genetics of ion-channel disorders

Genetics of cardiac arrhythmias and sudden cardiac death

Genetics of sudden death: focus on inherited channelopathies

Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes

Unraveling Complexities in Genetically Elusive Long QT Syndrome

Therapeutic strategies for long-QT syndrome: does the molecular substrate matter?

Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice

Actionable Variants of Unknown Significance in Inherited Arrhythmogenic Syndromes: A Further Step Forward in Genetic Diagnosis

Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia Diseases

Cardiac channelopathies in pediatrics: a genetic update

Molecular biology of the long QT syndrome: impact on management

Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death

Molecular Genetics of Long QT Syndrome from Genes to Patients

Inherited calcium channelopathies in the pathophysiology of arrhythmias

Catecholaminergic polymorphic ventricular tachycardia: a paradigm to understand mechanisms of arrhythmias associated to impaired Ca2+ regulation

Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome